Rethinking Solid Tumor Profiling: How Complementary Technologies Allow Better Treatment Decisions
1:00:10
Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
1:09:40
Webinar: A Pharmacogenetic (PGx) Blindspot: The Prevalence and Impact of CYP2D6 Hybrid Alleles
52:58
Advocating for DPYD Testing to Advance Patient Safety Based on Insights from Clinical Evidence
37:26
Cancer Immunotherapy Basics: Understand the science behind this cutting-edge treatment
30:12
Episode 9 | Incidence, Causes and Treatment of Pelvic Congestion Syndromes
1:00:41
Webinar: PGx Testing Developments and Future Directions
43:43
Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLC
33:10